|Winter Showcase 2022
January 4th to 13th (Online & San Francisco)
We cordially invite you to join our “ACCESS CHINA Biotech Forum @ JPM Week 2022” to be held online from January 4th to 13th 2022. As the largest CHINA corporate access event during the JPM WEEK in 2022, the forum expects to have over 1000 participants from China pharma and biotech companies. The two-week event is divided into the following sessions:
- Keynote Speeches
- China Innovation Day
- China Biotech Presentations
- Global Biotech Roadshows
- South Korea Biotech Presentations
- YAFO East-Meet-West Dinner in SF
Witness the emergence of China biotech innovation
We look forward to welcoming you at our winter showcase in January!
ACCESS CHINA Biotech Forum Committee
Two-Week ACCESS CHINA Biotech Forum Agenda
Jan. 4th - 7th
Jan. 10th - 13th
Who should present ?
- Looking for out-/in-licensing opportunities in China
- With clinical-stage pharmaceutical assets
- Focusing on Oncology, CNS, Cardiovascular, Ophthalmology, Orthopedics, Pediatrics, GI, and other therapeutic areas
Who are the attendees ?
- 50% are Chinese pharma/biotechs looking for in-licensing opportunities to enrich pipeline
- 25% are pharma/biotechs outside China looking for in-licensing opportunities to enrich pipeline in China and other regions
- 15% are VCs and PEs looking for pharma/biotech investment opportunities
|80% are C-level executives & BDs|
How to register?
For registration, please go to: https://jinshuju.net/f/AqkB9m?x_field_1=FCF
To apply for a “Presenting Slot”, you simply need to fill in and submit the application form along with your company presentation. Once approved by AC Forum Committee, you will be offered a slot to present.
ACCESS CHINA past events
ACCESS CHINA is a series of events that YAFO organizes each year, including East-Meet-West Mixing Dinner @ JPM Week, CHINA Biotech Forum (each September in China), and ACCESS CHINA Online Partnering. During 2021 we have helped 300+ companies present their products in front of global pharma and VC/PEs. Some presenters have successfully partnered in China after presenting.
KOLs & Speakers @ ACCESS CHINA 2021
During ACCESS CHINA Biotech Forum @ JPM Week 2021, we invited dozens of key opinion leaders in China pharma industry and the top biotech to share their views of the industry, the trend and the top-tier technology.
Summit Chair, CHBD
BD Head, Servier China
CEO, Swiss Biotech Association
Founder&President, Renexes LLC
Senior Director of BD Becton Dickinson
Global Partner, Mckinsey
Chief Analyst, Industrial Securities
SVP BD, JW Therapeutics
Director of Search and Evaluation Pacific BD&L Hub, MSD
BD Director Huadong Medicine
Chief Analyst, the pharmaceutical industry, Southwest Securities
BD Head, Bayer China
Previous attendees from China
ACCESS CHINA Online Partnering Day
Presentation Submission & Review
|Company submits application form with partnering objectives (licensing, capital raising, M&A, etc)|
|ACCESS CHINA Committee will review the opportunity in the related therapeutic areas and accept the application.|
|YAFO Life Sciences banking team will help you to prepare and coordinate for the conference day.|
|Company will present either via recording presentation or live presentation. Presentation will be available on demand for 7 days after the live day|
Customized Exposure & Deal Closing
|YAFO will expose company to a larger and customized list based on our investor base in related therapeutic area (for YAFO clients only).|
|Facilitate the signing of LOI/Term Sheet, Due Diligence, and closing of the transaction.|
JOIN US WHEN YOU ARE READY
For global biopharma companies
No need to wait for months to spend time and money for a physical event in China. As ACCESS CHINA has 4 Online Partnering Day events through the year, you are welcome to join us when you are ready.
For Chinese biopharma companies
ACCESS CHINA has strong coverage of pharmaceutical and biotech companies from North America, Europe, MENA and APAC regions. This offers you an ideal channel to meet with potential outlicensing or commercial partners in different regions.